High pathological response rate after neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer (NICHE-2 study). Sallinen V. Gastroenterology 2024 Aug 6:S0016-5085(24)05303.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sallinen V. High pathological response rate after neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer (NICHE-2 study). Gastroenterology 2024 Aug 6:S0016-5085(24)05303.
PMID: 39117120